Nursing Assessment of Early Sepsis Without Classic Clinical Signs
DOI:
https://doi.org/10.22399/ijcesen.4730Keywords:
Early Sepsis, Nursing Assessment, Atypical Presentation, Clinical Signs, Sepsis Recognition, Clinical JudgmentAbstract
Nursing assessment of early sepsis in the absence of classic clinical signs, such as fever or overt hypotension, represents a critical and complex challenge requiring heightened clinical vigilance and a multifaceted approach. This scenario is particularly common in vulnerable populations like the elderly, immunocompromised patients, and those with chronic comorbidities, who may present with non-specific symptoms such as acute confusion, generalized weakness, malaise, or isolated organ dysfunction. Effective identification hinges on a nurse’s comprehensive and holistic assessment that integrates subtle physiological trends—including minimal alterations in vital signs, skin perfusion, or cognitive status—with a detailed patient history and early biomarker analysis, notably serum lactate. It necessitates moving beyond protocol-driven checklists to employ sophisticated clinical judgment, recognizing that early sepsis can manifest as a subtle deviation from the patient's baseline. The nurse's role is pivotal in initiating timely interventions, advocating for further diagnostic evaluation, and coordinating the multidisciplinary response, ultimately bridging the gap between atypical presentation and life-saving treatment to mitigate the high morbidity and mortality associated with delayed sepsis recognition.
References
1. Menichetti F, Sganga G. Definition and classification of intra-abdominal infections. J Chemother. 2009;21:3–4.
2. Magill SS, Klompas M, Balk R, Burns SM, Deutschman CS, Diekema D, et al. Developing a new, national approach to surveillance for ventilator-associated events. Crit Care Med. 2013;41:2467–2475.
3. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med. 2003;31:1250–1256.
4. Ramphal R. Importance of adequate initial antimicrobial therapy. Chemotherapy. 2005;51:171–176.
5. Ranieri VM, Taylor T, Philip SB, Jean-François D, Ivor SD, Simon F, et al. Drotrecogin alfa (activated) in adults with septic shock. N Engl J Med. 2012;366:2055–2064.
6. Kumar G, Nilay K, Amit T, Thomas K, Sergey T, Emily M, et al. Nationwide trends of severe sepsis in the 21st century (2000–2007) Chest. 2011;140:1223–1231.
7. Reissig A, Copetti R. Lung ultrasound in community-acquired pneumonia and in interstitial lung diseases. Respiration. 2014;87:179–189.
8. American Thoracic Society (2001) Guidelines for the management of adults with community-acquired pneumonia.
9. Klein K, Peter MC, David SYO, Marc JMB, Olaf LC. Classification of sepsis, severe sepsis and septic shock: the impact of minor variations in data capture and definition of SIRS criteria. Intensive Care Med. 2012;38:811–819.
10. Morelli A, Ertmer C, Westphal M, Rehberg S, Kampmeier T, Ligges S, et al. Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial. JAMA. 2013;310:1683–1691.
11. Zangrillo A, Biondi-Zoccai G, Landoni G, Frati G, Patroniti N, Pesenti A, et al. Extracorporeal membrane oxygenation (ECMO) in patients with H1N1 influenza infection: a systematicreview and meta-analysis including 8 studies and 266 patients receiving ECMO. Crit Care. 2013;17:R30.
12. Friedman G, Silva E, Vincent JL. Has the mortality of septic shock changed with time. Crit Care Med. 1998;26:2078–2086.
13. Lung M, Codina G. Molecular diagnosis in HAP/VAP. Curr Opin Crit Care. 2012;18:487–494.
14. Reynaldos CM, Györik T, Lora S, Gaia V, Pagnamenta A. ARDS with septic shock due to Legionella longbeachae pneumonia in a patient with polymyalgia rheumatic. Heart Lung Vessel. 2014;6:114–118.
15. Pasin L, Landoni G, Castro ML, Cabrini L, Belletti A, Feltracco P, et al. The effect of statins on mortality in septic patients: a meta-analysis of randomized controlled trials. PLoS One. 2013;12:e82775.
16. Rice LB. The clinical consequences of antimicrobial resistance. Curr Opin Microbiol. 2009;12:476–481.
17. Zangrillo A, Landoni G, Biondi-Zoccai G, Greco M, Greco T, Frati G, et al. A meta-analysis of complications and mortality of extracorporeal membrane oxygenation. Crit Care Resusc. 2013;15:172–178.
18. Klevens RM, Edwards JR, Richards LR, Jr, Horan TC, Gaynes RP, Pollock DA, et al. Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Rep. 2007;122:160–166.
19. Angus DC, Carlet J, 2002 Brussels Roundtable Participants Surviving intensive care: a report from the 2002 Brussels Roundtable. Intensive Care Med. 2003;29:368–377.
20. Annane D, Timsit JF, Megarbane B, Martin C, Misset B, Mourvillier B, et al. Recombinant human activated protein C for adults with septic shock: a randomized controlled trial. Am J Respir Crit Care Med. 2013;187:1091–1097.
21. Sundararajan V, Macisaac C, Presneill JJ, Cade JF, Visvanathan K. Epidemiology of sepsis in Victoria, Australia. Crit Care Med. 2005;33:71–80.
22. Schortgen F, Clabault K, Katsahian S, Devaquet J, Mercat A, Deye N, et al. Fever control using external cooling in septic shock: a randomized controlled trial. Am J Respir Crit Care Med. 2012;185:1088–1095.
23. Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP. The Natural History of the Systemic Inflammatory Response Syndrome (SIRS). A prospective study. JAMA. 1995;273:117–123.
24. American Thoracic Society, Infectious Diseases Society of America Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005;171:388–416.
25. Gattinoni L, Protti A, Caironi P, Carlesso E. Ventilator-induced lung injury: the anatomical and physiological framework. Crit Care Med. 2010;38:S539–S548.
26. Angus DC, van der Poll T. Severe sepsis and septic shock. NEJM. 2013;369:840–851.
27. Crivellari M, Della Valle P, Landoni G, Pappalardo F, Gerli C, Bignami E, et al. Human protein C zymogen concentrate in patients with severe sepsis and multiple organ failure after adult cardiac surgery. Intensive Care Med. 2009;35:1959–1963.
28. Moran BJ, Heald RJ. Risk factors for, and management of anastomotic leakage in rectal surgery. Colorectal Dis. 2001;3:135–137.
29. Brunkhorst FM, Oppert M, Marx G, Bloos F, Ludewig K, Putensen C, et al. Effect of empirical treatment with moxifloxacin and meropenem vs. meropenem on sepsis-related organ dysfunction in patients with severe sepsis: a randomized trial. JAMA. 2012;307:2390–2399.
30. Barbier F, Andremont F, Wolff M, Bouadma L. Hospital-acquired pneumonia and ventilator-associated pneumonia: recent advances in epidemiology and management. Curr Opin Pulm Med. 2013;19:216–228.
31. Eidelman LA, Putterman D, Putterman C, Sprung CL. The spectrum of septic encephalopathy. definitions, etiologies, and mortalities. JAMA. 1966;275:470–473.
32. Vincent J, Rello J, Marshall J. International study of the prevalence and outcomes of infection in intensive care units. JAMA. 2009;302:2323–2329.
33. Zimmerman JE, Andrew AK, William AK. Changes in hospital mortality for United States intensive care unit admissions from 1988 to 2012. Crit Care. 2013;17:R81.
34. Marshall JC, Innes M. Intensive care unit management of intra-abdominal infection. Crit Care Med. 2008;31:2228–2237.
35. Sartelli M, Viale P, Catena F, Ansaloni L, Moore E, Malangoni M, et al. 2013 WSES guidelines for management of intra-abdominal infections. World J Emerg Surg. 2013;8:3.
36. Dellinger RP, Mitchell ML, Andrew R, Djillali A, HerwigGerlach SM, Opal JE, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock. Crit Care Med. 2013;41:580–637.
37. Crivellari M, Silvetti S, Gerli C, Landoni G, Franco A, Bove T, et al. Protein C zymogen in adults with severe sepsis or septic shock. Med Intensiva. 2013;38:278–282.
38. Ricard JD, Dreyfuss D, Saumon G. Ventilator-induced lung injury. Eur Respir J. 2003;42:2s–9s.
39. Cruciani M. Meta-analyses of diagnostic tests in infectious diseases: how helpful are they in the intensive care setting? HSR Proc Intensive Care Cardiovasc Anesth. 2011;3:103–108.
40. Cohen J, Cristofaro P, Carlet J, Opal S. New method of classifying infections in critically Ill patients. Crit Care Med. 2004;32:1510–1526.
41. Guntupalli K, Nathan D, Peter EM, Venkata B, Benjamin M, Emanuel R, et al. A phase 2 randomized, double-blind, placebo-controlled study of the safety and efficacy of talactoferrin in patients with severe sepsis. Crit Care Med. 2013;41:706–716.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 International Journal of Computational and Experimental Science and Engineering
This work is licensed under a Creative Commons Attribution 4.0 International License.
